The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded an indefinite delivery contract to the UK Health Security Agency to support the Biomedical Advanced Research and Development Authority. The single award IDV has a potential value of $100 million and a period of performance through September 2027. Two task orders have been issued against the contract to date, totaling over $18 million, for biological animal model and medical countermeasure development services as well as contract management support. Services will be performed in Great Britain and the United Kingdom through September 2026.
The originating solicitation sought capability statements from small businesses to establish a Nonclinical Services Network providing expertise in three areas - animal model development and testing for biological agents, analytical method development and testing, and safety/toxicity testing - to support BARDA's advanced development of medical countermeasures against chemical, biological, radiological and nuclear threats. Respondents were required to demonstrate experience in developing animal models and conducting efficacy studies in compliance with FDA requirements. Multiple IDIQ contracts were anticipated for award in 2022 with minimum guarantees and task ordering to provide requested nonclinical development services.
Generated 1/4/24, 9:46 PM